Feb 28 (Reuters) - Endo International PLC ENDP.O :
* ENDO REPORTS FOURTH-QUARTER AND FULL-YEAR 2021 FINANCIAL
RESULTS
* Q4 ADJUSTED EARNINGS PER SHARE $0.84 FROM CONTINUING
OPERATIONS
* Q4 LOSS PER SHARE $2.38 FROM CONTINUING OPERATIONS
* Q4 REVENUE ROSE 4 PERCENT TO $789 MILLION
* SEES Q1 TOTAL REVENUES, NET $595 MILLION - $635 MILLION
* SEES Q1 ADJUSTED DILUTED NET INCOME PER SHARE FROM
CONTINUING
OPERATIONS $0.35 - $0.45
* Q4 2021 BRANDED PHARMACEUTICALS SEGMENT REVENUE WERE $228
MILLION, AN INCREASE OF 2% COMPARED TO $225 MILLION DURING Q4
2020
* Q4 EARNINGS PER SHARE VIEW $0.67, REVENUE VIEW $731.4
MILLION --
REFINITIV IBES DATA
Source text for Eikon: ID:nCNWxXhwNa
Further company coverage: ENDP.O